Skip to main content
Premium Trial:

Request an Annual Quote

PD to Use Illumina s BeadStation, Arrays to Study Genetic Variation

NEW YORK, Oct. 25 (GenomeWeb News) - PharmacoDesign will use Illumina's BeadStation system and whole-genome genotyping arrays and reagents to study genetic variations in various Korean populations, Illumina said today.


Under a worldwide royalty-bearing exclusive license, Illumina will incorporate biomarkers discovered by PharmacoDesign into proprietary SNP panels.


PharmacoDesign will utilize Illumina's Sentrix Human-1 BeadChip, containing over 100,000 SNP markers, and its Infinium assay for this project.


PharmacoDesign studies diseases that include obesity, cancer, and allergy-induced reactions such as atopy. The company works with large Korean hospitals to prescribe individualized treatments.


Financial details were not disclosed.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.